Thanks Jbeez, not here to judge but my experiences with Asia all start off with a welcoming hand and success turns into government regulation.
Daniel could give us some insights to the decision around Asian trails and how Australian shareholders would ultimate ly be in benefit. The logic of greater populations sounds great and just curious about the benefit to my shareholding.
Ann: First Patient Safely Combine Dosed in Phase 1 RC220 Trial, page-125
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.23 |
Change
0.015(1.24%) |
Mkt cap ! $212.8M | |||
| Open | High | Low | Value | Volume |
| $1.23 | $1.24 | $1.18 | $129.9K | 107.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 912 | $1.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 4775 | 1 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| RAC (ASX) Chart |